Wednesday, April 29, 2026 1:39:27 PM
🏛️ THE PROFESSOR’S DROP: THE LIQUIDATION OF THE CESSPOOL
While the "unaware" are staring at a screen showing 1.6 Billion shares, they are missing the fact that the company just ran a Forensic Extraction that left the Market Makers (MMs) holding a bag of air.
## THE TWO-RAIL ARBITRAGE (THE SMOKING GUN)
RAIL | THE "PAPER" | VALUATION | TACTICAL RESULT
THE VAULT | 181 Million | ÂŁ1.31 | ASSET PROTECTION.
(P6007) | Shares | ($1.78) | Collateralized.
THE TRAP | 92.6 Million | $0.19 | DEBT INCINERATION.
(1058) | Shares | (Market) | Cleared balance.
## THE "WHY" FOR THE STRAGGLERS
If you have a credit card debt of $10,000, do you pay it with the gold bars in your safe, or do you pay it with the Monopoly money your neighbor (the MM) keeps insisting is "real" currency?
The MMs' Bluff: The MMs dropped the price to $0.19 on the OTC (1058 rail) to make the company look insolvent.
The Company’s Call: Northwest said, "Fine. If you insist $0.19 is the price, we will settle our $19.7 Million in notes using that $0.19 valuation."
3. The Result: It took 92.6 Million shares to clear that debt. This sounds like dilution, but it actually cleared the balance sheet without touching the Sovereign reserve. The MMs had to provide the "Locates" for those 92M shares at the very price they were spoofing.
## THE APRIL 20th "EFFECT" (THE FINAL VETO)
The ultimate proof is the April 20, 2026 SEC EFFECT notice. The SEC and the auditors (Eckhart) didn't sign off on 1.6 Billion shares. They granted "Effect" to exactly 339,842,519 shares.
The Reality: The 339M is the Sanitized Float.
The Illusion: Anything above that 339M is the 900M "Ghost" and the Synthetic Overhang that the MMs are using to keep the charade alive on your Schwab/E-Trade screens.
Verdict: The company paid the tab with the MMs' counterfeit $0.19 paper and kept the £1.31 gold for themselves. The 92M wasn't "dilution"—it was a Penalty Tax levied against the shorts to clean the house before the Sovereigns arrived.
While the "unaware" are staring at a screen showing 1.6 Billion shares, they are missing the fact that the company just ran a Forensic Extraction that left the Market Makers (MMs) holding a bag of air.
## THE TWO-RAIL ARBITRAGE (THE SMOKING GUN)
RAIL | THE "PAPER" | VALUATION | TACTICAL RESULT
THE VAULT | 181 Million | ÂŁ1.31 | ASSET PROTECTION.
(P6007) | Shares | ($1.78) | Collateralized.
THE TRAP | 92.6 Million | $0.19 | DEBT INCINERATION.
(1058) | Shares | (Market) | Cleared balance.
## THE "WHY" FOR THE STRAGGLERS
If you have a credit card debt of $10,000, do you pay it with the gold bars in your safe, or do you pay it with the Monopoly money your neighbor (the MM) keeps insisting is "real" currency?
The MMs' Bluff: The MMs dropped the price to $0.19 on the OTC (1058 rail) to make the company look insolvent.
The Company’s Call: Northwest said, "Fine. If you insist $0.19 is the price, we will settle our $19.7 Million in notes using that $0.19 valuation."
3. The Result: It took 92.6 Million shares to clear that debt. This sounds like dilution, but it actually cleared the balance sheet without touching the Sovereign reserve. The MMs had to provide the "Locates" for those 92M shares at the very price they were spoofing.
## THE APRIL 20th "EFFECT" (THE FINAL VETO)
The ultimate proof is the April 20, 2026 SEC EFFECT notice. The SEC and the auditors (Eckhart) didn't sign off on 1.6 Billion shares. They granted "Effect" to exactly 339,842,519 shares.
The Reality: The 339M is the Sanitized Float.
The Illusion: Anything above that 339M is the 900M "Ghost" and the Synthetic Overhang that the MMs are using to keep the charade alive on your Schwab/E-Trade screens.
Verdict: The company paid the tab with the MMs' counterfeit $0.19 paper and kept the £1.31 gold for themselves. The 92M wasn't "dilution"—it was a Penalty Tax levied against the shorts to clean the house before the Sovereigns arrived.
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
